Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norepinephrine-Dopamine Releasing Agent (NDRA)
- Target
- NDRA
- Molecular classification
- Pharmacologic substance, Drug
01
Overview
Norepinephrine-dopamine releasing agents are psychostimulant drugs that increase levels of two key monoamines—norepinephrine and dopamine—by promoting their synaptic release. They play important roles clinically in treating disorders like ADHD and narcolepsy but also have potential for misuse due to their stimulant properties.
02
Mechanism of action
Promotes presynaptic norepinephrine and dopamine release.
03
Biological functions
Increase synaptic norepinephrine levelsIncrease synaptic dopamine levelsPsychostimulation
04
Disease associations
Treatment of ADHDTreatment of Binge Eating DisorderTreatment of ObesityTreatment of Narcolepsy
05
Safety considerations
Potential for misuse/abuseCardiovascular effectsPsychiatric side effects (anxiety, psychosis)Dependence
06
Interacting drugs
Amphetamine
13 more in the full profile.
Beyond the preview
Go deeper on Norepinephrine-Dopamine Releasing Agent (NDRA).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Norepinephrine-Dopamine Releasing Agent (NDRA).